Stock ADXN ADDEX THERAPEUTICS LTD
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Addex Therapeutics Ltd

Equities

ADXN

CH0029850754

Delayed Swiss Exchange
Other stock markets
 11:31:35 2024-06-07 am EDT 		5-day change 1st Jan Change
0.062 CHF -6.63% Intraday chart for Addex Therapeutics Ltd -13.41% +34.78%
Jun. 06 Transcript : Addex Therapeutics Ltd, Q1 2024 Earnings Call, Jun 06, 2024
Jun. 06 Addex Therapeutics' Q1 Net Loss Widens; Revenue Down MT

Evolution of the average Target Price on Addex Therapeutics Ltd

Price target over the last 5 years

History of analyst recommendation changes

4062f9b8d.qG39S6SYpdGbzh6RL0f6eGpQHVrwtMsPiTtvPmlYTLY.yS6QAM-riIjXl3DiVSagJ1oGSDCiwbh5vAo9cgIgLe_-GYoUzK3Ip86ZbQ~637aacb6ad7d31581e12e09ff3671c4f

Analyst Recommendations on Addex Therapeutics Ltd

Addex to Present at BioEURquity Europe 2024 DJ
HC Wainwright Downgrades Addex Therapeutics to Neutral From Buy MT
Addex Terminates Dipraglurant Phase 2b/3 Study in Patients with Dyskinesia Associated with Parkinson's Disease due to Slow Recruitment Rate DJ
Addex Terminates Dipraglurant Phase 2b/3 Study in Patients with Dyskinesia Associated with Parkinson's Disease due to Slow Recruitment Rate CI
HC Wainwright Adjusts Addex Therapeutics' Price Target to $15 From $21, Keeps Buy Rating MT
HC Wainwright Adjusts Addex Therapeutics' Price Target to $21 from $28, Maintains Buy Rating MT
ADDEX THERAPEUTICS : HC Wainwright Initiates Addex Therapeutics at Buy Rating With $28 Price Target MT
Addex Therapeutics : Van Leeuwenhoeck Issues Equity Research Note Highlighting Value of Recent Indivior Strategic Partnership on GABAB PAM GL
Addex Therapeutics : Van Leeuwenhoeck Issues Research Note on Addex Therapeutics GL
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
2
Last Close Price
0.062 CHF
Average target price
0.16 CHF
Spread / Average Target
+158.06%
High Price Target
0.16 CHF
Spread / Highest target
+158.06%
Low Price Target
0.16 CHF
Spread / Lowest Target
+158.06%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Addex Therapeutics Ltd

HC Wainwright

Ratings for Addex Therapeutics Ltd

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ADXN Stock
  4. Consensus Addex Therapeutics Ltd